| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/16/2006 | US7045597 Mast cell surface antigen, DNA thereof, and antibody against the antigen |
| 05/16/2006 | US7045596 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045595 For development of therapeutic drugs for diseases associated with immunity or hematopoiesis |
| 05/16/2006 | US7045594 Serine proteinase inhibitors |
| 05/16/2006 | US7045593 Using detergents; antiagglomerants; eukaryotic membrane protein |
| 05/16/2006 | US7045591 Cyclic peptide for use in the treatment of eating disorders |
| 05/16/2006 | US7045585 Methods of coating a device using anti-thrombin heparin |
| 05/16/2006 | US7045537 Polypeptide coiled strands; crosslinking |
| 05/16/2006 | US7045509 Proteins and nucleic acids encoding same |
| 05/16/2006 | US7045503 Radiometal-binding peptide analogues |
| 05/16/2006 | US7045501 Method of treating chronic cardiac disease |
| 05/16/2006 | US7045500 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 05/16/2006 | US7045498 Soluble Zcytor11 cytokine receptors |
| 05/16/2006 | US7045497 Use of peptide |
| 05/16/2006 | US7045363 Nucleotide-protein fusion; for use as a diagnostic tool in the decision of preferential particles |
| 05/16/2006 | US7045355 Genes encoding plant transcription factors |
| 05/16/2006 | US7045354 Semicontinuous culture of plant cells in a nutrient medium;monitoring the pH of the medium to monitor expression of an expression product encoded by a polynucleotide under the control of an inducible promoter; antitrypsin |
| 05/16/2006 | US7045350 Alternatively spliced circulating tissue factor |
| 05/16/2006 | US7045348 for gene transfer to dendritic cells; for immunotherapy; chimeras; genetic engineering; contains a fiber protein modified by insertion of a first zipper peptide that can crosslink to a fusion protein and a target ligand |
| 05/16/2006 | US7045346 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 05/16/2006 | US7045345 G-coupled receptor showing selective affinity for ATP |
| 05/16/2006 | US7045344 Adenoviral vector and methods for making and using the same |
| 05/16/2006 | US7045337 Translation system for use in the generation of protein containing adjusted amino acid sequences |
| 05/16/2006 | US7045329 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 05/16/2006 | US7045324 Tocopherol associated protein (TAP-38) DNA/protein with a 76 nucleotide base deletion resulting in a 25 amino acid deletion, followed by 90 novel nucleotides that code for 30 novel amino acids that are not expressed by TAP-46. The |
| 05/16/2006 | US7045318 Recombinant fusion proteins to growth hormone and serum albumin |
| 05/16/2006 | US7045317 Bardet-biedl susceptibility gene and uses thereof |
| 05/16/2006 | US7045316 Nucleotide sequences coding transport protein for use in the transfer of drugs in cells |
| 05/16/2006 | US7045314 Method for the production of bacterial toxins |
| 05/16/2006 | US7045313 plasmid containing multiple restriction endonuclease sites comprising a ploypeptide foreign to the vaccina virus or other poxvirus, a virus promoter sequence and a DNA segment from a nonessential regin of the vaccina genome; for expression of the foreign gene after cell or animal infection |
| 05/16/2006 | US7045310 Measuring the concentration of preferential analyte in sample; obtain samples, incubate with binding particles, determine concentration of detectable particles |
| 05/16/2006 | US7045306 assay comprising transcriptional and cognate activators with Huntington's disease mutant protein; linked to detectable sequence within neuron; for preventing or treating a neurodegenerative disease associated with an expanded polyglutamine tract |
| 05/16/2006 | US7045303 cell-based assays designed to identify compounds that regulate the activity of polycystin; increased adherence to type I collagen coated surfaces; apical expression of NaK-ATPase on the cell membrane |
| 05/16/2006 | US7045302 Expressed ligand-vascular intercellular signaling molecule |
| 05/16/2006 | US7045301 Genetic engineering; prevention, therapy of cancer |
| 05/16/2006 | US7045300 Isolated, purified plant extract; anticancer agents; bonding n-acetylneuraminic acid to protein |
| 05/16/2006 | US7045299 Digestive diseases; amino acid sequence 20 or 21; specific to orphan receptor protein ZAQ |
| 05/16/2006 | US7045284 Reducing translation of Rna virus; genetic engineered nucleic acids |
| 05/16/2006 | US7045280 Assay method |
| 05/16/2006 | US7045136 Methods of immunization using recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences |
| 05/16/2006 | US7045133 VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor |
| 05/16/2006 | US7045132 Comprises nucleotide sequences coding adhesion polypeptides for treating infection; bactericides; genetic vaccines |
| 05/16/2006 | US7045129 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3 |
| 05/16/2006 | US7045128 Antibodies against flt3-ligand |
| 05/16/2006 | US7045123 DNA encoding Pseudomonas syringae hypersensitive response elicitor and its use |
| 05/16/2006 | CA2260296C Variants of human ciliary neurotrophic factor (hcntf) with a range of action different from that of the wild-type molecule |
| 05/16/2006 | CA2147468C Method for producing polypeptide via bacterial fermentation |
| 05/16/2006 | CA2129183C Bispecific trigger molecules recognizing lymphocyte antigen cd2 and tumor antigens |
| 05/11/2006 | WO2006050498A2 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| 05/11/2006 | WO2006050262A2 Compositions and methods for modification of biomolecules |
| 05/11/2006 | WO2006050041A2 Methods for reducing or inhibiting brain inflammation or for promoting neurogenesis |
| 05/11/2006 | WO2006049789A1 Intraoperative method for isolating and concentrating autologous growth factors and for forming residual autologous growth factor compositions |
| 05/11/2006 | WO2006049423A1 Human interferon-beta mutein |
| 05/11/2006 | WO2006048777A2 Modified growth hormones |
| 05/11/2006 | WO2006048768A2 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 05/11/2006 | WO2006048763A1 Anti-bacterial vaccine compositions |
| 05/11/2006 | WO2006048757A2 Anti-bacterial vaccine compositions |
| 05/11/2006 | WO2006048662A1 Pseudotyped baculovirus and its use |
| 05/11/2006 | WO2006048657A2 Fras related protein |
| 05/11/2006 | WO2006048655A2 Methods of modulating the immune system using anti-inflammatory polypeptides which interact with toll receptor function |
| 05/11/2006 | WO2006048555A1 Peptide exhibiting, in particular an anti-hiv activity, method for the preparation thereof and a pharmaceutical composition containing said peptide |
| 05/11/2006 | WO2006048452A2 Peptides for use in treating of obesity |
| 05/11/2006 | WO2006048451A1 Peptides for use in the treatment of obesity |
| 05/11/2006 | WO2006048450A2 Peptides for use in the treating obesity |
| 05/11/2006 | WO2006048234A2 Diagnosis and therapy of autophagy-associated diseases |
| 05/11/2006 | WO2006048021A1 Use of neublasmin as a marker for testis cancer |
| 05/11/2006 | WO2006012627A3 Actrii receptor polypeptides, methods and compositions |
| 05/11/2006 | WO2005117994A3 Bmp pathway methods and compositions |
| 05/11/2006 | WO2005116212A3 Treatment of neurodegenerative disease through intracranial delivery of sirna |
| 05/11/2006 | WO2005114209A3 Diagnostics and therapeutics for diseases associated with g protein-dependent receptor kinase 2 (grk2) |
| 05/11/2006 | WO2005112568A3 Haplotype markers and methods of using the same to determine response to treatment |
| 05/11/2006 | WO2005108422A3 Ammonium/ammonia transporter |
| 05/11/2006 | WO2005107364A9 Polynucleotide, polypeptides, and diagnostic methods |
| 05/11/2006 | WO2005106471A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 4 (ccr4) |
| 05/11/2006 | WO2005105839A3 Essential tremor diagnostic and treatment |
| 05/11/2006 | WO2005105836A3 Methods and materials for improving plant drought tolerance |
| 05/11/2006 | WO2005092924A3 Rab9a, rab11a, and modulators thereof related to infectious disease |
| 05/11/2006 | WO2005090389A3 Isosteric transformation |
| 05/11/2006 | WO2005082929A3 Beak and feather disease virus sequences, compositions and vaccines and the use thereof in therapy, diagnosis and assays |
| 05/11/2006 | WO2005072766A3 Peptides that bind to hsp90 proteins |
| 05/11/2006 | WO2005056764A3 Inhibitors of type 2 vascular endothelial growth factor receptors |
| 05/11/2006 | WO2005048951A3 A novel human g-protein coupled receptor, hgprbmy8, expressed highly in brain |
| 05/11/2006 | WO2005047461A3 Polypeptide display libraries and methods of making and using thereof |
| 05/11/2006 | WO2005019414A3 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
| 05/11/2006 | WO2005003177A3 Molecules for the targeting and the in situ assembly of therapeutic proteins and use thereof |
| 05/11/2006 | WO2004022578A3 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis |
| 05/11/2006 | WO2002055100A9 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 05/11/2006 | US20060101532 Methods for the identification of compounds for the treatment of Alzheimer's disease |
| 05/11/2006 | US20060101530 Rors as modifiers of the p21 pathway and methods of use |
| 05/11/2006 | US20060101529 Lymphocyte surface receptor that binds CAML and methods of use thereof |
| 05/11/2006 | US20060100419 Prekallikrein depleted plasma derived albumin fraction |
| 05/11/2006 | US20060100418 Cultured xenopus cell line expressing mutated apc |
| 05/11/2006 | US20060100417 Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and uses thereof |
| 05/11/2006 | US20060100416 Novel substitution mutant receptors and their use in an nuclear receptor-based inducible gene expression system |
| 05/11/2006 | US20060100153 HSulf-1 nucleic acids, polypeptides and methods of using |
| 05/11/2006 | US20060100149 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 05/11/2006 | US20060100148 Glutathione-S-transferase tag, hexahistidine tag, maltose binding protein tag, haemagglutinin tag, and cellulose binding protein; for treating and preventing Flaviviridae virus (e.g., hepatitis C virus) infections |
| 05/11/2006 | US20060100147 Anticancer peptide |
| 05/11/2006 | US20060100145 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 05/11/2006 | US20060100143 Polypeptide |